LANDUCCI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.996
EU - Europa 5.999
AS - Asia 3.366
SA - Sud America 366
AF - Africa 110
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.911
PL - Polonia 2.320
RU - Federazione Russa 1.328
IT - Italia 1.056
SG - Singapore 979
CN - Cina 861
HK - Hong Kong 533
IE - Irlanda 329
VN - Vietnam 290
BR - Brasile 287
SE - Svezia 255
KR - Corea 249
FR - Francia 153
FI - Finlandia 133
DE - Germania 128
IN - India 96
GB - Regno Unito 88
BD - Bangladesh 67
CH - Svizzera 65
JO - Giordania 59
ID - Indonesia 49
TR - Turchia 49
AU - Australia 46
NL - Olanda 45
CA - Canada 44
JP - Giappone 43
MX - Messico 29
UA - Ucraina 29
AR - Argentina 26
CI - Costa d'Avorio 22
ZA - Sudafrica 21
NG - Nigeria 19
ES - Italia 18
IQ - Iraq 18
BE - Belgio 13
PK - Pakistan 13
EC - Ecuador 11
PY - Paraguay 11
CO - Colombia 10
EG - Egitto 10
PH - Filippine 8
MA - Marocco 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BJ - Benin 6
CL - Cile 6
LB - Libano 5
LT - Lituania 5
MY - Malesia 5
PE - Perù 5
SA - Arabia Saudita 5
AT - Austria 4
BO - Bolivia 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
JM - Giamaica 4
MU - Mauritius 4
NP - Nepal 4
TN - Tunisia 4
VE - Venezuela 4
BG - Bulgaria 3
DK - Danimarca 3
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
NO - Norvegia 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
GM - Gambi 1
GR - Grecia 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
Totale 16.885
Salva come PNG Salva come JPEG
Città #
Warsaw 2.316
Santa Clara 1.440
Ashburn 887
Singapore 696
Fairfield 507
Hong Kong 467
Chandler 327
Dublin 325
San Jose 248
Woodbridge 245
Seoul 242
Seattle 223
Beijing 203
Cambridge 191
Houston 182
Wilmington 182
Hefei 161
Milan 154
Council Bluffs 153
Ann Arbor 144
Florence 144
The Dalles 132
Buffalo 123
Los Angeles 107
Dallas 89
Lawrence 86
Altamura 83
Lauterbourg 77
Ho Chi Minh City 76
Rome 74
Princeton 73
Moscow 67
Brunswick 60
Hanoi 59
Shanghai 55
Bern 54
Helsinki 52
Boston 50
Munich 50
Melbourne 43
Jakarta 41
San Diego 41
Dearborn 40
Paris 39
Tokyo 39
Boardman 37
Dong Ket 36
Medford 36
New York 36
Mumbai 35
Kent 31
Turin 31
Phoenix 30
São Paulo 30
Naples 28
Turku 28
Clifton 23
Jacksonville 23
Abidjan 22
Frankfurt am Main 22
London 20
Redondo Beach 20
Bologna 19
Falls Church 18
Orem 18
Guangzhou 16
Lappeenranta 16
Abuja 15
Atlanta 15
Chennai 15
Da Nang 13
Washington 13
Brussels 12
Figino 12
Miano 12
San Francisco 12
Toronto 12
Bengaluru 11
Haiphong 11
Montreal 11
Belo Horizonte 10
Johannesburg 10
Brasília 9
Hillsboro 9
Norwalk 9
Palermo 9
Yubileyny 9
Dhaka 8
Fort Wayne 8
Genoa 8
North Bergen 8
Salt Lake City 8
Brooklyn 7
Charlotte 7
Chicago 7
Curitiba 7
Denver 7
Izmir 7
Manchester 7
Modena 7
Totale 11.947
Salva come PNG Salva come JPEG
Nome #
Anticonvulsant and Neuroprotective Effects of the Thyroid Hormone Metabolite 3-Iodothyroacetic Acid. 444
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism 362
3-Iodothyroacetic acid (TA1), a by-product of thyroid hormone metabolism, reduces the hypnotic effect of ethanol without interacting at GABA-A receptors. 349
Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo 345
Arrays of MicroLEDs and Astrocytes: Biological Amplifiers to Optogenetically Modulate Neuronal Networks Reducing Light Requirement 338
Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. 336
The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice 334
In the brain of mice,3-iodothyronamine(T1AM) is converted into 3-iodothyroaceticacid(TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 311
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold 306
Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance 305
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability 303
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 300
Interplay between histone acetylation/deacetylation and poly(ADPribosyl)ation in the development of ischemic tolerance in vitro 291
Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue. 290
N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity 285
Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors 278
Brain histamine modulates the antidepressant-like effect of the 3-iodothyroacetic acid (TA1) 273
Glutamate receptor and transporter modifications in rat organotypic hippocampal slice cultures exposed to oxygen-glucose deprivation: The contribution of cyclooxygenase-2 266
Glutamate Receptor-Mediated Neurotoxicity in a Model of Ethanol Dependence and Withdrawal in Rat Organotypic Hippocampal Slice Cultures 257
Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases. 256
A new ophthalmic formulation containing antiseptics and dexpanthenol: In vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells 254
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 253
The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models 247
Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin 244
Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain 240
Bicuculline Reverts the Neuroprotective Effects of Meloxicam in an Oxygen and Glucose Deprivation (OGD) Model of Organotypic Hippocampal Slice Cultures 235
Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model 227
Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation 217
Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur Citrus Extract 210
BRAIN-TARGETED DELIVERY OF ANDROGRAPHOLIDE USING SOLID LIPID NANOPARTICLES: IN VITRO AND IN VIVO EVALUATION 210
3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes. 208
The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation 205
Ethanol Toxicity During Brain Development: Alterations of Excitatory Synaptic Transmission in Immature Organotypic Hippocampal Slice Cultures 200
Evaluation of Conventional and Hyaluronic Acid-Coated Thymoquinone Liposomes in an In Vitro Model of Dry Eye 198
Using organotypic hippocampal slice cultures to gain insight into mechanisms responsible for the neuroprotective effects of meloxicam: A role for gamma aminobutyric and endoplasmic reticulum stress 196
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors 190
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 189
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study 186
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model 185
CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices 184
Neuroprotective effects of thymoquinone by the modulation of ER stress and apoptotic pathway in in vitro model of excitotoxicity. 182
Differential mechanisms of tolerance induced by NMDA and DHPG preconditioning 180
Rat hippocampal slice culture models for the evaluation of neuroprotective agents. 174
Neuroprotective effects of cannabidiol but not Δ9-tetrahydrocannabinol in rat hippocampal slices exposed to oxygen-glucose deprivation: studies with Cannabis extracts and selected cannabinoids. 174
Enhanced Neuroprotective Effects of Panax Ginseng G115® and Ginkgo Biloba GK501® Combinations In Vitro Models of Excitotoxicity 173
Virtual screening and in vitro experiments highlight cannabidiol as a drug-like phosphodiesterase 9 inhibitor 171
Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance 171
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: in vitro test and in vivo toxicity assessment in Zebrafish embryos. 168
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia 166
Preparation of liposomal formulations for ocular delivery of thymoquinone: in vitro evaluation in HCEC-2 e HConEC cells. 166
Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K–Akt signaling pathway: A novel postconditioning strategy? 165
Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic–ischaemic encephalopathy 163
DHPG and NMDA preconditioning induce ischemic tolerance with differential mechanisms 163
Interplay between group I mGlu and the endocannabinoid system in the hippocampus: studies in models of cerebral ischemia 162
Tolerance Induced by (S)-3,5-Dihydroxyphenylglycine Postconditioning is Mediated by the PI3K/Akt/GSK3β Signalling Pathway in an In Vitro Model of Cerebral Ischemia 159
Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model 158
An electrophysiological study of the mGlu1 receptors ability to modulate endocannabinoids production and inhibitory synaptic transmission in the CA1 hippocampal area 154
Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol 152
mGlu1 receptors and endocannabinoids: neuroprotection studies in an in vitro model of cerebral ischemia 149
Nerve growth factor (NGF) mimetics modulate ischemic brain damage 148
Applications of innovative technologies to the antipsychotics delivery. 147
Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol. 145
The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism 142
Neurotoxicity of Unconjugated Bilirubin in Mature and Immature Rat Organotypic Hippocampal Slice Cultures 141
Nerve Growth Factor mimetics with neuroprotective activity in ischemic brain damage 141
Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy 139
Prolonged incubation with Δ9-tetrahydrocannabinol but not with cannabidiol induces synaptic alterations and mitochondrial impairment in immature and mature rat organotypic hippocampal slices 139
Preconditioning With NMDA and DHPG Induces Ischemic Tolerance With Differential Mechanisms In An In Vitro Hippocampal Slice Model Of Excitotoxicity 137
Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake 134
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. 134
Dual action of sphingosine 1-phosphate pathway in in vitro models of global cerebral ischemia 131
Preconditioning with NMDA, but not DHPG, induces tolerance to excitotoxicity by internalization of AMPA receptors. 130
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia 128
Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization 123
Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases 122
Cannabidiol preferentially binds TRPV2: a novel mechanism of action 120
Mild activation of ionotropic and metabotropic glutamate receptors induces ischemic tolerance with differential mechanisms in rat organotypic hippocampal slices 119
Interplay between mGlu1 and CB1 receptors in the postischemic CA1 hippocampal area: Neuroprotection and anatomical studies. 111
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: an electrophysiological study 105
Neuroprotection following postconditioning via group I mGlu receptor activation is coupled to the PI3K/Akt/GSK3β signalling pathway in a rat organotypic hippocampal slice model of cerebral ischemia 102
Preconditioning with NMDA and DHPG induces ischemic tolerance with differential mechanisms in an in vitro hippocampal slice model 100
MPP+-dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons 93
NMDA and DHPG preconditioning induce ischemic tolerance with differential mechanisms in rat organotypic hippocampal slices 93
Improved super-bright microLEDs for bi-dimensional optogenetic applications and opto-electronic retinal prosthesis. 92
Interactions between mGlu1 receptors and endocannabinoids in the pathophysiology of hippocampal post-ischemic neuronal death 75
8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemia 69
Article Vitamin D Nanoliposomes to Improve Solubility, Stability, and Uptake Across Intestinal Barrier 48
Sex-Dependent Long-Term Neurobehavioral Recovery in Experimental Neonatal Hypoxic-Ischemic Encephalopathy 36
Cutamesine attenuates hippocampal damage via sigma-1 receptor activation following oxygen-glucose deprivation in vitro 29
Totale 17.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022519 17 30 36 18 14 47 36 35 29 32 88 137
2022/20231.523 117 261 79 88 111 252 191 91 198 14 49 72
2023/2024646 20 77 89 24 59 68 36 143 16 33 55 26
2024/20254.342 156 372 226 603 1.271 585 83 323 229 108 197 189
2025/20265.386 560 635 516 341 586 168 672 276 388 383 194 667
2026/202730 30 0 0 0 0 0 0 0 0 0 0 0
Totale 17.030